Back to search

Article

Myeloid reprogramming by JAK inhibition enhances checkpoint blockade therapy

2022-06-26

Abstract excerpt

Unleashing anti-tumor T cell activity by checkpoint inhibition is effective in many cancer patients but clinical response rates remain limited. Myeloid derived suppressor cells erode antitumor lymphocyte numbers and function, and correlate with resistance to checkpoint inhibitors. By screening small molecule libraries, we identified JAK inhibitors’ ability to rescue T cell function. Despite its documented immune s...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ff3b2570-0eda-574f-b060-1c318883662c
DOI
10.1101/2022.06.24.497435
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Myeloid reprogramming by JAK inhibition enhances checkpoint blockade therapyDOI 10.1101/2022.06.24.497435
Select a neighboring publication to make it the new centre.